1887

Journal of General Virology header logo

Volume 88, Issue 10

Enzymatic detergent treatment protocol that reduces protease-resistant prion protein load and infectivity from surgical-steel monofilaments contaminated with a human-derived prion strain Free

Abstract

The unconventional nature of the infectious agent of prion diseases poses a challenge to conventional infection control methodologies. The extraneural tissue distribution of variant and sporadic Creutzfeldt–Jakob disease has increased concern regarding the risk of prion disease transmission via general surgical procedures and highlighted the need for decontamination procedures that can be incorporated into routine processing. In this study, the ability of preparations of enzymatic medical instrument cleaners to reduce the infectivity associated with a rodent-adapted strain of human prion disease, previously reported to be resistant to decontamination, was tested. Efficient degradation of the disease-associated prion protein by enzymatic cleaning preparations required high treatment temperatures (50–60 °C). Standard decontamination methods (1 M NaOH for 1 h or autoclaving at 134 °C for 18 min) reduced infectivity associated with the human-derived prion strain by less than 3 log LD. In contrast, a 30 min treatment with the optimized enzymatic cleaning preparation protocols reduced infectivity by more than 3 log LD and when used in conjunction with autoclave cycles eliminated detectable levels of infectivity. The development of prion decontamination procedures that are compatible with routine cleaning and sterilization of medical and surgical instruments may reduce the risk of the transmission of prion disease in general surgery.

  • Received:
  • Accepted:
  • Published Online:
SGM
Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.82961-0
2007-10-01
2024-04-16
Loading full text...

Full text loading...

/deliver/fulltext/jgv/88/10/2905.html?itemId=/content/journal/jgv/10.1099/vir.0.82961-0&mimeType=html&fmt=ahah

References

  1. Bolton D. C., Bendheim P. E., Marmorstein A. D., Potempska A. 1987; Isolation and structural studies of the intact scrapie agent protein. Arch Biochem Biophys 258:579–590 [CrossRef]
     [Google Scholar]
  2. Brazier M. W., Lewis V., Ciccotosto G. D., Klug G. M., Lawson V. A., Cappai R., Ironside J. W., Masters C. L., Hill A. F. other authors 2006; Correlative studies support lipid peroxidation is linked to PrPres propagation as an early primary pathogenic event in prion disease. Brain Res Bull 68:346–354 [CrossRef]
     [Google Scholar]
  3. Cheetham N. W. H., Berentsveig V. 2002; Relative efficacy and activity of medical instrument cleaning agents. Aust Infect Control 7:105–112
     [Google Scholar]
  4. Collins S., Law M. G., Fletcher A., Boyd A., Kaldor J., Masters C. L. 1999; Surgical treatment and risk of sporadic Creutzfeldt–Jakob disease: a case–control study. Lancet 353:693–697 [CrossRef]
     [Google Scholar]
  5. Collins S. J., Lewis V., Brazier M. W., Hill A. F., Lawson V. A., Klug G. M., Masters C. L. 2005; Extended period of asymptomatic prion disease after low dose inoculation: assessment of detection methods and implications for infection control. Neurobiol Dis 20:336–346 [CrossRef]
     [Google Scholar]
  6. Deleault N. R., Lucassen R. W., Supattapone S. 2003; RNA molecules stimulate prion protein conversion. Nature 425:717–720 [CrossRef]
     [Google Scholar]
  7. Deleault N. R., Harris B. T., Rees J. R., Supattapone S. 2007; From the cover: formation of native prions from minimal components in vitro . Proc Natl Acad Sci U S A 104:9741–9746 [CrossRef]
     [Google Scholar]
  8. Editorial team. 2007; Fourth case of transfusion-associated vCJD infection in the United Kingdom. Euro Surveill 12:E070118–4
     [Google Scholar]
  9. Fichet G., Comoy E., Duval C., Antloga K., Dehen C., Charbonnier A., McDonnell G., Brown P., Lasmezas C. I., Deslys J. P. 2004; Novel methods for disinfection of prion-contaminated medical devices. Lancet 364:521–526 [CrossRef]
     [Google Scholar]
  10. Fischer M., Rulicke T., Raeber A., Sailer A., Moser M., Oesch B., Brandner S., Aguzzi A., Weissmann C. 1996; Prion protein (PrP) with amino-proximal deletions restoring susceptibility of PrP knockout mice to scrapie. EMBO J 15:1255–1264
     [Google Scholar]
  11. Flechsig E., Hegyi I., Enari M., Schwarz P., Collinge J., Weissmann C. 2001; Transmission of scrapie by steel-surface-bound prions. Mol Med 7:679–684
     [Google Scholar]
  12. Glatzel M., Abela E., Maissen M., Aguzzi A. 2003; Extraneural pathologic prion protein in sporadic Creutzfeldt–Jakob disease. N Engl J Med 349:1812–1820 [CrossRef]
     [Google Scholar]
  13. Hilton D. A., Ghani A. C., Conyers L., Edwards P., McCardle L., Ritchie D., Penney M., Hegazy D., Ironside J. W. 2004; Prevalence of lymphoreticular prion protein accumulation in UK tissue samples. J Pathol 203:733–739 [CrossRef]
     [Google Scholar]
  14. Ironside J. W., Bishop M. T., Connolly K., Hegazy D., Lowrie S., Le Grice M., Ritchie D. L., McCardle L. M., Hilton D. A. 2006; Variant Creutzfeldt–Jakob disease: prion protein genotype analysis of positive appendix tissue samples from a retrospective prevalence study. Br Med J 332:1186–1188 [CrossRef]
     [Google Scholar]
  15. Jackson G. S., McKintosh E., Flechsig E., Prodromidou K., Hirsch P., Linehan J., Brandner S., Clarke A. R., Weissmann C., Collinge J. 2005; An enzyme-detergent method for effective prion decontamination of surgical steel. J Gen Virol 86:869–878 [CrossRef]
     [Google Scholar]
  16. Kasermann F., Kempf C. 2003; Sodium hydroxide renders the prion protein PrPSc sensitive to proteinase K. J Gen Virol 84:3173–3176 [CrossRef]
     [Google Scholar]
  17. Kimberlin R. H., Walker C. A., Millson G. C., Taylor D. M., Robertson P. A., Tomlinson A. H., Dickinson A. G. 1983; Disinfection studies with two strains of mouse-passaged scrapie agent. Guidelines for Creutzfeldt–Jakob and related agents. J Neurol Sci 59:355–369 [CrossRef]
     [Google Scholar]
  18. Kocisko D. A., Lansbury P. T. Jr, Caughey B. 1996; Partial unfolding and refolding of scrapie-associated prion protein: evidence for a critical 16-kDa C-terminal domain. Biochemistry 35:13434–13442 [CrossRef]
     [Google Scholar]
  19. Kuczius T., Groschup M. H. 1999; Differences in proteinase K resistance and neuronal deposition of abnormal prion proteins characterize bovine spongiform encephalopathy (BSE) and scrapie strains. Mol Med 5:406–418
     [Google Scholar]
  20. Lee D. C., Stenland C. J., Hartwell R. C., Ford E. K., Cai K., Miller J. L., Gilligan K. J., Rubenstein R., Fournel M., Petteway S. R., Jr. 2000; Monitoring plasma processing steps with a sensitive Western blot assay for the detection of the prion protein. J Virol Methods 84:77–89 [CrossRef]
     [Google Scholar]
  21. Lemmer K., Mielke M., Pauli G., Beekes M. 2004; Decontamination of surgical instruments from prion proteins: in vitro studies on the detachment, destabilization and degradation of PrPSc bound to steel surfaces. J Gen Virol 85:3805–3816 [CrossRef]
     [Google Scholar]
  22. Llewelyn C. A., Hewitt P. E., Knight R. S., Amar K., Cousens S., Mackenzie J., Will R. G. 2004; Possible transmission of variant Creutzfeldt–Jakob disease by blood transfusion. Lancet 363:417–421 [CrossRef]
     [Google Scholar]
  23. McDonnell G., Burke P. 2003; The challenge of prion decontamination. Clin Infect Dis 36:1152–1154 [CrossRef]
     [Google Scholar]
  24. Peden A. H., Head M. W., Ritchie D. L., Bell J. E., Ironside J. W. 2004; Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 364:527–529 [CrossRef]
     [Google Scholar]
  25. Peden A. H., Ritchie D. L., Head M. W., Ironside J. W. 2006; Detection and localization of PrPSc in the skeletal muscle of patients with variant, iatrogenic, and sporadic forms of Creutzfeldt–Jakob disease. Am J Pathol 168:927–935 [CrossRef]
     [Google Scholar]
  26. Peretz D., Supattapone S., Giles K., Vergara J., Freyman Y., Lessard P., Safar J. G., Glidden D. V., McCulloch C. other authors 2006; Inactivation of prions by acidic sodium dodecyl sulfate. J Virol 80:322–331 [CrossRef]
     [Google Scholar]
  27. Prusiner S. B., Cochran S. P., Groth D. F., Downey D. E., Bowman K. A., Martinez H. M. 1982; Measurement of the scrapie agent using an incubation time interval assay. Ann Neurol 11:353–358 [CrossRef]
     [Google Scholar]
  28. Reed L. J., Muench H. 1938; A simple method of estimating fifty percent endpoints. Am J Hyg 27:493–497
     [Google Scholar]
  29. Tateishi J., Ohta M., Koga M., Sato Y., Kuroiwa Y. 1979; Transmission of chronic spongiform encephalopathy with kuru plaques from humans to small rodents. Ann Neurol 5:581–584 [CrossRef]
     [Google Scholar]
  30. Tateishi J., Tashima T., Kitamoto T. 1988; Inactivation of the Creutzfeldt–Jakob disease agent. Ann Neurol 24:466 [CrossRef]
     [Google Scholar]
  31. Tateishi J., Tashima T., Kitamoto T. 1991; Practical methods for chemical inactivation of Creutzfeldt–Jakob disease pathogen. Microbiol Immunol 35:163–166 [CrossRef]
     [Google Scholar]
  32. Taylor D. M. 2000; Inactivation of transmissible degenerative encephalopathy agents: a review. Vet J 159:10–17 [CrossRef]
     [Google Scholar]
  33. Taylor D. M., Fernie K. 1996; Exposure to autoclaving or sodium hydroxide extends the dose–response curve of the 263K strain of scrapie agent in hamsters. J Gen Virol 77:811–813 [CrossRef]
     [Google Scholar]
  34. Vella L. J., Sharples R. A., Lawson V. A., Masters C. L., Cappai R., Hill A. F. 2007; Packaging of prions into exosomes is associated with a novel pathway of PrP processing. J Pathol 211:582–590 [CrossRef]
     [Google Scholar]
  35. Wadsworth J. D., Joiner S., Hill A. F., Campbell T. A., Desbruslais M., Luthert P. J., Collinge J. 2001; Tissue distribution of protease resistant prion protein in variant Creutzfeldt–Jakob disease using a highly sensitive immunoblotting assay. Lancet 358:171–180 [CrossRef]
     [Google Scholar]
  36. Weissmann C., Enari M., Klohn P. C., Rossi D., Flechsig E. 2002; Transmission of prions. J Infect Dis 186 (Suppl. 2):S157–S165 [CrossRef]
     [Google Scholar]
  37. White A. R., Enever P., Tayebi M., Mushens R., Linehan J., Brandner S., Anstee D., Collinge J., Hawke S. 2003; Monoclonal antibodies inhibit prion replication and delay the development of prion disease. Nature 422:80–83 [CrossRef]
     [Google Scholar]
  38. Yan Z. X., Stitz L., Heeg P., Pfaff E., Roth K. 2004; Infectivity of prion protein bound to stainless steel wires: a model for testing decontamination procedures for transmissible spongiform encephalopathies. Infect Control Hosp Epidemiol 25:280–283 [CrossRef]
     [Google Scholar]
  39. Zobeley E., Flechsig E., Cozzio A., Enari M., Weissmann C. 1999; Infectivity of scrapie prions bound to a stainless steel surface. Mol Med 5:240–243
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.82961-0
Loading
Enzymatic detergent treatment protocol that reduces protease-resistant prion protein load and infectivity from surgical-steel monofilaments contaminated with a human-derived prion strain
J. Gen. Virol. 88, 2905 (2007); https://doi.org/10.1099/vir.0.82961-0
/content/journal/jgv/10.1099/vir.0.82961-0
/content/journal/jgv/10.1099/vir.0.82961-0
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error